Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA study): Results of a phase 1 dose-escalation study
- Rogério A. Costa
- , Rodrigo Jorge
- , Daniela Calucci
- , José A. Cardillo
- , Luiz A.S. Melo
- , Ingrid U. Scott
Research output: Contribution to journal › Article › peer-review
156
Link opens in a new tab
Scopus
citations